Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Grifols (GRFS) has a market cap of $5.71 billion USD. According to our data, Grifols is ranked No.2362 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $5.71 B |
198.31%
|
| Dec 31, 2024 | $1.92 B |
-35.64%
|
| Dec 29, 2023 | $2.98 B |
36.00%
|
| Dec 30, 2022 | $2.19 B |
-24.31%
|
| Dec 31, 2021 | $2.89 B |
-37.47%
|
| Dec 31, 2020 | $4.62 B |
-19.87%
|
| Dec 31, 2019 | $5.77 B |
29.29%
|
| Dec 31, 2018 | $4.46 B |
-18.07%
|
| Dec 29, 2017 | $5.45 B |
45.07%
|
| Dec 30, 2016 | $3.75 B |
1.41%
|
| Dec 31, 2015 | $3.70 B |
-2.57%
|
| Dec 31, 2014 | $3.80 B |
-4.40%
|
| Dec 31, 2013 | $3.97 B |
40.70%
|
| Dec 31, 2012 | $2.82 B |
146.17%
|
| Dec 30, 2011 | $1.15 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 CSL
CSL.AX
|
$74.79 B |
-0.212 B
|
Australia
|
 Baxter
BAX
|
$14.26 B |
0.000 M
|
USA
|
 Kamada
KMDA
|
$0.36 B |
-0.000 M
|
Israel
|
 ADMA Biologics
ADMA
|
$5.26 B |
-0.000 M
|
USA
|
 Emergent BioSolutions
EBS
|
$0.25 B |
0.000 M
|
USA
|
 Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
Japan
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
| Market Cap | = | GRFS Stock Price | * | GRFS Shares Outstanding |
| = | $6.99 | * | 0.26 B | |
| = | $5.71 B |